Ikarian Capital, LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$843,000
-54.5%
131,310
-75.7%
0.17%
-50.3%
Q2 2022$1,854,000
-69.0%
540,624
-35.7%
0.34%
-57.1%
Q1 2022$5,986,000
-9.7%
840,624
+5.6%
0.79%
-20.3%
Q4 2021$6,630,000
+57.0%
795,903
+31.2%
0.99%
+232.7%
Q3 2021$4,222,000
-64.6%
606,554
+21.3%
0.30%
-69.2%
Q2 2021$11,924,000
-48.8%
500,000
-55.8%
0.96%
+23.0%
Q1 2021$23,267,000
+178.4%
1,130,000
+231.3%
0.78%
+113.0%
Q4 2020$8,357,000
-65.6%
341,100
-60.2%
0.37%
-79.1%
Q3 2020$24,286,000
+747.1%
857,830
+42.4%
1.76%
+670.6%
Q2 2020$2,867,000602,3000.23%
Other shareholders
SERES THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders